Results

Total Results: 559 records

Showing results for "resistance".

241. • The roles of the psychiatric hospital, lengths of stay, and transition support services after discharge | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/the-roles-of-the-psychiatric-hospital-lengths-of-stay-and-transition-support-services-after-discharge
     November 01, 2017 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

242. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
     January 01, 2007 - Layout 1 Background Aripiprazole, olanzapine, quetiapine, risperidone, and ziprasidone are atypical antipsychotics approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia and bipolar disorder. These drugs have been studied for off-label use in the following conditions: dementia and seve…

243. Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/major-depressive-disorder/research-protocol
     December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

244. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Some experts stated risk of hearing loss, cardiac arrhythmias, and antibiotic resistance are factors

245. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
     January 01, 2011 - dialysis (i.e., peritoneal or hemodialysis)  Patient subgroups (i.e., age, sex, comorbid conditions, ESA resistance … subgroups, type of dialysis, different reference standards --: Dialysis type; patient subgroups; ESA resistance

246. Chronic-Kidney-Disease-Anemia-2011 Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
     January 01, 2011 - erythropoiesis; however, decreased iron stores or iron availability are the most common reasons for resistance … hemodialysis) • Patient subgroups (i.e., age, sex, comorbid conditions, erythropoiesis-stimulating agent resistance … Patient subgroups (i.e., age, sex, comorbid conditions, erythropoiesis-stimulating agent resistance

247. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - might be concerned about the potential for overprescribing antibiotics and an increase in microbial resistance … Since this changes the workflow, there would be resistance. … be apprehensive about utilizing antibiotics at increasing rates due to concerns about antibiotic resistance

248. Hepatitis-C-Treatment-Adherence Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_executive.pdf
     September 22, 2011 - interventions in improving intermediate (e.g., sustained viral response, histological changes, drug resistance … Early viral response • Sustained viral response • Histological changes • Biochemical markers • Drug resistance … interventions in improving intermediate (e.g., sustained viral response, histological changes, drug resistance

249. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 08: Functional Limitations and Disability Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov …

250. Evidence Report No. 222, Data Linkage Strategies To Advance Youth Suicide Prevention (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/suicide-prevention_research.pdf
     October 01, 2016 - Evidence Report No. 222, Data Linkage Strategies To Advance Youth Suicide Prevention Evidence Report/Technology Assessment Number 222 Data Linkage Strategies To Advance Youth Suicide Prevention Evidence-Based Practice Evidence Report/Technology Assessment Number 222 Data Linkage Strategies To Advance Y…

251. Treatment for Bipolar Disorder | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/bipolar-disorder-treatment/research-protocol
     December 01, 2019 - Outcomes by comorbidity and treatment resistance   Lithium Treatment Resistant Comorbid Substance

252. Microsoft Word - finbody.doc (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
     January 01, 2007 - Microsoft Word - finbody.doc This report is based on research conducted by the Tufts-New England Medical Center Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0022). The findings and conclusions in this d…

253. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
     January 01, 2012 - compromised in patients with AD. 33,34 Additionally, “peripheral insulin abnormalities” (e.g., insulin resistance … unclear whether the therapy will provide ongoing benefit or whether patients may develop insulin resistance

254. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - CER #55: Drug Therapy for Rheumatoid Arthritis in Adults: An Update Original release date: April, 2012 Surveillance Report: May, 2013 Key Findings: • For Key Question 1, conclusion on comparative effectiveness of biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs) is probably out of date. Conclu…

255. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - CER #55: Drug Therapy for Rheumatoid Arthritis in Adults: An Update Original release date: April, 2012 Surveillance Report: May, 2013 Key Findings: • For Key Question 1, conclusion on comparative effectiveness of biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs) is probably out of date. Conclu…

256. First and Second Generation Antipsychotics for Children and Young Adults-Comparative Effectiveness Review Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/antipsychotics-children-update/research-protocol
     April 01, 2020 - metabolic syndrome, change in body composition [weight, BMI], fasting glucose, insulin sensitivity/resistance … = hemoglobin A1c; HDL = high-density lipoprotein; HOMA–IR = homeostasis model assessment of insulin resistance … cholesterol, LDL and HDL cholesterol, triglycerides, ratio of triglycerides to HDL cholesterol Insulin resistance

257. McCormack-notes-151008 copy - Teresa (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/mccormack-presentation.pdf
     November 12, 2015 - McCormack-notes-151008 copy - Teresa My talk today is about engaging patients with  low health  literacy. 1 Health literacy is a key factor in securing access to healthcare services. So in my talk today, I’ll talk a little bit about health literacy and what it is, how we measure health literacy and the sta…

258. For persons with PTSD (and those exposed to traumatic event/s as defined by DSM-IV-TR or ICD-10), what is the comparative effectiveness of different psychotherapy modalities/psychological treatments? o Is EMDR an effective treatment for… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-persons-with-ptsd-and-those-exposed-to-traumatic-events-as-defined-by-dsm-iv-tr-or-icd-10-what-is-the-comparative-effectiveness-of-different-psychotherapy-modalitiespsychological-treatments-o-is-emdr-an-effective-treatme
     November 01, 2017 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

259. Community Forum Deliberative Methods Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/deliberative-methods/research-2013-1
     January 01, 2019 - should be considered, potential tradeoffs in values, and potential solutions and their likely uptake or resistance

260. Tympanostomy Tubes | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/tympanostomy-tubes/research-protocol
     March 01, 2021 - recurrent AOM. 13 The reluctance to use antibiotic prophylaxis because of concerns about antibiotic resistance